Hyro Secures $20 Million Series B for Conversational and Generative AI in Healthcare

Conversational AI startup, Hyro, announced the closing of a $20 million Series B funding round led by Macquarie Capital, with participation from Liberty Mutual Strategic Ventures, Black Opal Ventures, K20, as well as existing investors Hanaco Ventures, Spero Ventures, and Mindset Ventures. The latest round brings the startup's total funding to $35 million.

Hyro, founded in 2020, facilitates enterprises in automating workflows and conversations across multiple platforms, services, and channels—including call centers, websites, SMS, mobile apps, and more. Since its launch, Hyro has registered an exponential annual recurring revenue growth of over 100%. The company, delivering top-notch conversational experiences, has served over 30 million enterprise consumers, leading to substantial operational savings.

Forecasts indicate that nearly half of the current US-based healthcare workforce will exit the industry by 2025, positioning Hyro to harness the increasing demand for AI and natural language understanding (NLU) solutions. The startup was recognized in 2022 as a Gartner Cool Vendor for its unique natural language processing (NLP) and knowledge graph technologies. Their chat and voice interfaces are capable of resolving up to 85% of routine tasks for healthcare organizations.

Hyro's Conversational Intelligence is unlike typical conversational AI solutions, including those based on LLMs. Their analytics dashboard provides performance metrics, popular trends, and explainability surrounding AI outputs, enabling full visibility and a consistent feedback loop for organizations to further optimize their data. Hyro also recently released their Generative AI tool, Spot™, a GPT-powered assistant proficient at instantly generating answers to FAQs and search queries using customized enterprise data.

This fresh influx of capital will serve to expand its talent pool across all departments to continue the development of its no-code platform.